Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

83.3%

-3.2% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

60%

3 of 5 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

2(40.0%)

5Total

N/A(3)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04246229Not ApplicableNot Yet Recruiting

Transcutaneous Bilirubinometry and Phototherapy

Role: lead

NCT02913040Not ApplicableCompleted

High Flow in Infants With Bronchiolitis

Role: lead

NCT01622699Not ApplicableCompleted

Implementation of a Transcutaneous Bilirubinometer

Role: lead

NCT00962299Phase 4Terminated

Effectiveness of Inhaled Corticosteroids in Preschool Children With Acute Dyspnea and Wheeze

Role: lead

NCT01441466Completed

Cohort Isolation and Cross-infection in Bronchiolitis

Role: lead

NCT01714076Completed

Co-infections in Children Hospitalised for Bronchiolitis

Role: lead

NCT00962754Phase 4Completed

Fluid Balance Study in Sick Neonates

Role: lead

All 7 trials loaded